“After evaluating the received data, the EMA can recommend the use of the Moderna vaccine for adolescents aged 12 to 17 years… The use of the vaccine in children from the age of 12 will be the same as in other age categories: the vaccine is administered in two doses to the shoulder muscle at intervals of four weeks,” the document says.
Until recently, Moderna was approved for use in the EU from the age of 18. Currently, the Pfizer/BioNTech vaccine is already used in the European Union to vaccinate adolescents from the age of 12.
In total, four vaccines are approved for use in adults in the EU: Pfizer/Biotech, Moderna, AstraZeneca, and Johnson&Johnson. Several other drugs are under consideration by the regulator, including the Russian Sputnik V vaccine.
The European Union intends to fully vaccinate 70% of the adult population against coronavirus by the end of July. At the moment, almost 55% of adult residents of the union have already been fully vaccinated.